On September 1, Synopsys declined 3.04% in regular trading, trading at $426.815/share with turnover of $40.28 million, extending a multi-session slide following its fiscal Q3 earnings report.

On the news front, while Synopsys posted a strong Q3 beat — adjusted EPS of $3.91 versus the $3.67 consensus and revenue of $2.48 billion versus the $2.44 billion estimate, representing 42% year-over-year growth — the stock has faced sustained selling pressure as multiple analysts lowered their price targets. BofA Securities cut its target from $600 to $500 while maintaining a buy rating; Mizuho reduced its target from $600 to $550; Morgan Stanley trimmed its target from $525 to $500; and Wells Fargo previously slashed its target from $535 to $450. The full-year revenue guidance of $9.69 billion to $9.74 billion only marginally exceeded the $9.68 billion Street consensus, fueling concerns about growth sustainability and triggering profit-taking after an initial 13% Baird-upgrade bounce on August 28.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)